Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Lotus Eye Hospital and Institute Ltd. (LOTUSEYE)
Market Closed
10 Aug, 10:00
XNSE
All
(3)
IN
(3)
XNSE
Primary
MSE
MSE
₹
115.
61
-3.21
-2.7016%
₹
2.19B
Market Cap
34.88
P/E Ratio
0.5%
Div Yield
13,828
Volume
0
Eps
₹
118.82
Previous Close
Watching
Watch
Add Transaction
Day Range
115.21
118.55
Year Range
72.1
147
Want to track
LOTUSEYE
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
Historical Data
Lotus Eye Hospital and Institute Ltd. (LOTUSEYE) Statistics
Valuation metrics
Market Cap
2.19B
Enterprise value
2.59B
Trailing P/E (ttm)
2,970.5
Forward P/E
-
PEG ratio
-33.42
Price/Sales (ttm)
4.6
Price/Book (mrq)
4.21
Enterprise Value/Revenue
4.82
Enterprise Value/EBITDA
59.99
Overview
Shares outstanding
20.8M
Float
4.56M
Shares short
-
% Held by insiders
0.72%
% Held by institutions
-
Average volume (10 days)
8.83K
Average volume (90 days)
31.45K
Price summary
52-Week low
72.1
52-Week high
147
Beta
0.5
50-Day moving average
121.2
200-Day moving average
116.51
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0%
Operating margin
-0.01%
Operational effectiveness
Return on assets
0%
Return on equity
0%
Income Statement
Revenue (ttm)
516.17M
Revenue per share (ttm)
25.22
Quarterly revenue growth (yoy)
0.11%
Gross profit (ttm)
106.01M
EBITDA
45.25M
Net income to common (ttm)
6.52M
Diluted EPS (ttm)
0.04
Quarterly earnings growth (yoy)
0.11%
Balance Sheet
Total cash (mrq)
32.49M
Total cash per share (mrq)
1.8
Total debt (mrq)
47.99M
Total Debt/Equity (mrq)
0.26
Current ratio (mrq)
1.22%
Book value per share (mrq)
28.23
Cash Flow
Cash flow statement
5.77M
Levered free cash flow (LFCF)
7.39M